170 related articles for article (PubMed ID: 29682647)
1. Reversibly disulfide cross-linked micelles improve the pharmacokinetics and facilitate the targeted, on-demand delivery of doxorubicin in the treatment of B-cell lymphoma.
Xiao K; Liu Q; Al Awwad N; Zhang H; Lai L; Luo Y; Lee JS; Li Y; Lam KS
Nanoscale; 2018 May; 10(17):8207-8216. PubMed ID: 29682647
[TBL] [Abstract][Full Text] [Related]
2. PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma.
Xiao K; Luo J; Li Y; Lee JS; Fung G; Lam KS
J Control Release; 2011 Oct; 155(2):272-81. PubMed ID: 21787818
[TBL] [Abstract][Full Text] [Related]
3. Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery.
Li Y; Xiao K; Luo J; Xiao W; Lee JS; Gonik AM; Kato J; Dong TA; Lam KS
Biomaterials; 2011 Sep; 32(27):6633-45. PubMed ID: 21658763
[TBL] [Abstract][Full Text] [Related]
4. Targeted glioma chemotherapy by cyclic RGD peptide-functionalized reversibly core-crosslinked multifunctional poly(ethylene glycol)-b-poly(ε-caprolactone) micelles.
Fang Y; Jiang Y; Zou Y; Meng F; Zhang J; Deng C; Sun H; Zhong Z
Acta Biomater; 2017 Mar; 50():396-406. PubMed ID: 28065871
[TBL] [Abstract][Full Text] [Related]
5. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
[TBL] [Abstract][Full Text] [Related]
6. cRGD-functionalized reduction-sensitive shell-sheddable biodegradable micelles mediate enhanced doxorubicin delivery to human glioma xenografts in vivo.
Zhu Y; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z
J Control Release; 2016 Jul; 233():29-38. PubMed ID: 27178807
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin loaded pH-sensitive micelle targeting acidic extracellular pH of human ovarian A2780 tumor in mice.
Gao ZG; Lee DH; Kim DI; Bae YH
J Drug Target; 2005 Aug; 13(7):391-7. PubMed ID: 16308207
[TBL] [Abstract][Full Text] [Related]
8. Quantification of DOX bioavailability in biological samples of mice by sensitive and precise HPLC assay.
Zhang C; Wu Y; Dong Y; Xu H; Zhao L
Pharm Biol; 2016; 54(1):55-61. PubMed ID: 25880143
[TBL] [Abstract][Full Text] [Related]
9. Cationic drug-based self-assembled polyelectrolyte complex micelles: Physicochemical, pharmacokinetic, and anticancer activity analysis.
Ramasamy T; Poudel BK; Ruttala H; Choi JY; Hieu TD; Umadevi K; Youn YS; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2016 Oct; 146():152-60. PubMed ID: 27318960
[TBL] [Abstract][Full Text] [Related]
10. Aptamer-drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity.
Dou XQ; Wang H; Zhang J; Wang F; Xu GL; Xu CC; Xu HH; Xiang SS; Fu J; Song HF
Int J Nanomedicine; 2018; 13():763-776. PubMed ID: 29440899
[TBL] [Abstract][Full Text] [Related]
11. Self-crosslinkable and intracellularly decrosslinkable biodegradable micellar nanoparticles: A robust, simple and multifunctional nanoplatform for high-efficiency targeted cancer chemotherapy.
Zou Y; Fang Y; Meng H; Meng F; Deng C; Zhang J; Zhong Z
J Control Release; 2016 Dec; 244(Pt B):326-335. PubMed ID: 27245309
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapy.
Sun J; Liu Y; Chen Y; Zhao W; Zhai Q; Rathod S; Huang Y; Tang S; Kwon YT; Fernandez C; Venkataramanan R; Li S
J Control Release; 2017 Jul; 258():43-55. PubMed ID: 28501705
[TBL] [Abstract][Full Text] [Related]
13. In situ diselenide-crosslinked polymeric micelles for ROS-mediated anticancer drug delivery.
Deepagan VG; Kwon S; You DG; Nguyen VQ; Um W; Ko H; Lee H; Jo DG; Kang YM; Park JH
Biomaterials; 2016 Oct; 103():56-66. PubMed ID: 27372421
[TBL] [Abstract][Full Text] [Related]
14. Structure-directing star-shaped block copolymers: supramolecular vesicles for the delivery of anticancer drugs.
Yang C; Liu SQ; Venkataraman S; Gao SJ; Ke X; Chia XT; Hedrick JL; Yang YY
J Control Release; 2015 Jun; 208():93-105. PubMed ID: 25813888
[TBL] [Abstract][Full Text] [Related]
15. Disulfide cross-linked micelles of novel HDAC inhibitor thailandepsin A for the treatment of breast cancer.
Xiao K; Li YP; Wang C; Ahmad S; Vu M; Kuma K; Cheng YQ; Lam KS
Biomaterials; 2015 Oct; 67():183-93. PubMed ID: 26218744
[TBL] [Abstract][Full Text] [Related]
16. A54 Peptide Modified and Redox-Responsive Glucolipid Conjugate Micelles for Intracellular Delivery of Doxorubicin in Hepatocarcinoma Therapy.
Liu N; Tan Y; Hu Y; Meng T; Wen L; Liu J; Cheng B; Yuan H; Huang X; Hu F
ACS Appl Mater Interfaces; 2016 Dec; 8(48):33148-33156. PubMed ID: 27934140
[TBL] [Abstract][Full Text] [Related]
17. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
[TBL] [Abstract][Full Text] [Related]
18. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J
Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117
[TBL] [Abstract][Full Text] [Related]
19. Disulfide cross-linked polyurethane micelles as a reduction-triggered drug delivery system for cancer therapy.
Yu S; Ding J; He C; Cao Y; Xu W; Chen X
Adv Healthc Mater; 2014 May; 3(5):752-60. PubMed ID: 24574261
[TBL] [Abstract][Full Text] [Related]
20. Reduction-Responsive Polypeptide Micelles for Intracellular Delivery of Antineoplastic Agent.
Xu W; Ding J; Chen X
Biomacromolecules; 2017 Oct; 18(10):3291-3301. PubMed ID: 28877434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
